These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 10685739)

  • 41. Efficacy of low-dose lansoprazole in the treatment of non-erosive gastrooesophageal reflux disease. Influence of infection by Helicobacter pylori.
    Castro Fernández M; García Díaz E; Larraona JL; Rodríguez Hornillo MC; Lamas Rojas E; Núñez Hospital D; Pallarés Querol M
    Rev Esp Enferm Dig; 2006 Mar; 98(3):170-9. PubMed ID: 16737416
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Drugs, bugs, and esophageal pH profiles.
    Robinson M
    Yale J Biol Med; 1999; 72(2-3):169-72. PubMed ID: 10780578
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Famotidine in gastroesophageal reflux disease (GERD).
    Wesdorp IC
    Hepatogastroenterology; 1992 Feb; 39 Suppl 1():24-6. PubMed ID: 1577391
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Omeprazole versus high-dose ranitidine in mild gastroesophageal reflux disease: short- and long-term treatment. The Dutch Reflux Study Group.
    Festen HP; Schenk E; Tan G; Snel P; Nelis F
    Am J Gastroenterol; 1999 Apr; 94(4):931-6. PubMed ID: 10201459
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Eosinophilic infiltration of the esophagus: gastroesophageal reflux versus eosinophilic esophagitis in children--discussion on daily practice.
    Cury EK; Schraibman V; Faintuch S
    J Pediatr Surg; 2004 Feb; 39(2):e4-7. PubMed ID: 14966764
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Omeprazole versus ranitidine or ranitidine/metoclopramide in poorly responsive symptomatic gastroesophageal reflux disease.
    Richter JE; Sabesin SM; Kogut DG; Kerr RM; Wruble LD; Collen MJ
    Am J Gastroenterol; 1996 Sep; 91(9):1766-72. PubMed ID: 8792695
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Chronic cough and gastroesophageal reflux disease: experience with specific therapy for diagnosis and treatment.
    Poe RH; Kallay MC
    Chest; 2003 Mar; 123(3):679-84. PubMed ID: 12628862
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Meta-analysis of randomized clinical trials comparing lansoprazole with ranitidine or famotidine in the treatment of acute duodenal ulcer.
    Poynard T; Lemaire M; Agostini H
    Eur J Gastroenterol Hepatol; 1995 Jul; 7(7):661-5. PubMed ID: 8590162
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Role of esophageal motility abnormalities in severe reflux esophagitis].
    Xu JY; Xie XP; Hou XH
    Zhonghua Nei Ke Za Zhi; 2005 May; 44(5):353-5. PubMed ID: 16009005
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Therapeutic choices in reflux disease: defining the criteria for selecting a proton pump inhibitor.
    Freston JW
    Am J Med; 2004 Sep; 117 Suppl 5A():14S-22S. PubMed ID: 15478848
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Preventive therapy for non-steroidal anti-inflammatory drug-induced ulcers in Japanese patients with rheumatoid arthritis: the current situation and a prospective controlled-study of the preventive effects of lansoprazole or famotidine.
    Miyake K; Ueki N; Suzuki K; Shinji Y; Kusunoki M; Hiratsuka T; Nishigaki H; Tatsuguchi A; Futagami S; Wada K; Tsukui T; Nakajima A; Yoshino S; Sakamoto C
    Aliment Pharmacol Ther; 2005 Jun; 21 Suppl 2():67-72. PubMed ID: 15943850
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The medical management of reflux esophagitis. Role of antacids and acid inhibition.
    Sontag SJ
    Gastroenterol Clin North Am; 1990 Sep; 19(3):683-712. PubMed ID: 1977703
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Lansoprazole-induced improvement of esophageal submucosal injury.
    Mine S; Tanaka Y
    J Clin Biochem Nutr; 2007 Sep; 41(2):92-6. PubMed ID: 18193102
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Reflux esophagitis: a comparative study of lansoprazole and omeprazole as short-term therapy. Preliminary report].
    Córdova-Villalobos JA; Ramírez-Barba EJ; Ramírez-Covarrubias JC
    Rev Gastroenterol Mex; 1996; 61(4):306-9. PubMed ID: 9072780
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Does short-term treatment with proton pump inhibitors cause rebound aggravation of symptoms?
    Farup PG; Juul-Hansen PH; Rydning A
    J Clin Gastroenterol; 2001 Sep; 33(3):206-9. PubMed ID: 11500608
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Lansoprazole versus omeprazole in the treatment of reflux esophagitis.
    Vcev A; Stimac D; Vceva A; Rubinić M; Ivandić A; Ivanis N; Horvat D; Volarić M; Karner I
    Acta Med Croatica; 1997; 51(3):171-4. PubMed ID: 9248117
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Lansoprazole versus omeprazole in short-term treatment of reflux oesophagitis. Results of a Scandinavian multicentre trial.
    Hatlebakk JG; Berstad A; Carling L; Svedberg LE; Unge P; Ekström P; Halvorsen L; Stallemo A; Hovdenak N; Trondstad R
    Scand J Gastroenterol; 1993 Mar; 28(3):224-8. PubMed ID: 8446846
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Human gastric carcinoid detected during long-term antiulcer therapy of H2 receptor antagonist and proton pump inhibitor.
    Haga Y; Nakatsura T; Shibata Y; Sameshima H; Nakamura Y; Tanimura M; Ogawa M
    Dig Dis Sci; 1998 Feb; 43(2):253-7. PubMed ID: 9512115
    [No Abstract]   [Full Text] [Related]  

  • 59. Endoscopic ultrasonographic evaluation of gastric ulcer healing on treatment with proton pump inhibitors versus H2-receptor antagonists.
    Tanaka M; Maruoka A; Chijiiwa Y; Tanaka M; Nawata H
    Scand J Gastroenterol; 1994 Dec; 29(12):1140-4. PubMed ID: 7886404
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Progress with proton pump inhibitors in acid peptic disease: treatment of duodenal and gastric ulcer.
    Florent C
    Clin Ther; 1993; 15 Suppl B():14-21. PubMed ID: 7911399
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.